Global Receptor Tyrosine Kinase Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Name: Global Receptor Tyrosine Kinase Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Brand: KnowledgeNJournals Research
SKU: Pharmaceuticals and Healthcare
Price: 3980 USD
Availability: InStock
Rating: 4.5 (37 reviews)

Report Code: KNJ1027186 | No. of Pages: 129 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Nov-2021

Executive Summary

According to GRD Survey data, the global Receptor Tyrosine Kinase Treatment market was valued at  million US$ in 2020 and is expected to reach  million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.

This report studies the Receptor Tyrosine Kinase Treatment market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Receptor Tyrosine Kinase Treatment in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    EGFR Tyrosine Kinase Inhibitors
    VEGFR Tyrosine Kinase Inhibitors
    PDGFR Tyrosine Kinase Inhibitors
    Others

Market Snapshot, By Application
    Lung Cancer
    Breast Cancer
    Renal Cell Cancer
    Others

Main Market Players Analyzed in this report, including:
    Roche
    Pfizer
    Novartis
    Merck KGaA
    Johnson and Johnson
    GlaxoSmithKline
    Eton Bioscience
    Bristol-Myers Squibb
    Boehringer Ingelheim
    AstraZeneca

The study objectives of this report are:
    To study and analyze the global Receptor Tyrosine Kinase Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Receptor Tyrosine Kinase Treatment market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Receptor Tyrosine Kinase Treatment manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Receptor Tyrosine Kinase Treatment market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Receptor Tyrosine Kinase Treatment submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Receptor Tyrosine Kinase Treatment are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Receptor Tyrosine Kinase Treatment Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Receptor Tyrosine Kinase Treatment Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Receptor Tyrosine Kinase Treatment

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Receptor Tyrosine Kinase Treatment Sales Channel and Distributors Analysis
        3.3.1 Receptor Tyrosine Kinase Treatment Sales Channel
        3.3.2 Receptor Tyrosine Kinase Treatment Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Lung Cancer
        3.4.2 Major Buyers in Breast Cancer
    3.5 Receptor Tyrosine Kinase Treatment Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Receptor Tyrosine Kinase Treatment Type Introduction
        4.1.1 EGFR Tyrosine Kinase Inhibitors
        4.1.2 VEGFR Tyrosine Kinase Inhibitors
        4.1.3 PDGFR Tyrosine Kinase Inhibitors
        4.1.4 Others
    4.2 Global Receptor Tyrosine Kinase Treatment Sales by Type 2016-2021
    4.3 Global Receptor Tyrosine Kinase Treatment Revenue by Type 2016-2021
    4.4 Global Receptor Tyrosine Kinase Treatment Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Receptor Tyrosine Kinase Treatment Type Introduction
        5.1.1 Lung Cancer
        5.1.2 Breast Cancer
        5.1.3 Renal Cell Cancer
        5.1.3 Others
    5.2 Global Receptor Tyrosine Kinase Treatment Sales by Application 2016-2021
    5.3 Global Receptor Tyrosine Kinase Treatment Revenue by Application 2016-2021
    5.4 Global Receptor Tyrosine Kinase Treatment Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Receptor Tyrosine Kinase Treatment Market by Region
        6.1.1 Global Receptor Tyrosine Kinase Treatment Sales by Regions
        6.1.2 Global Receptor Tyrosine Kinase Treatment Revenue by Regions
    6.2 North America Receptor Tyrosine Kinase Treatment Market 2016-2021
    6.3 Europe Receptor Tyrosine Kinase Treatment Market 2016-2021
    6.4 Asia Pacific Receptor Tyrosine Kinase Treatment Market 2016-2021
    6.5 South America Receptor Tyrosine Kinase Treatment Market 2016-2021
    6.6 Middle East and Africa Receptor Tyrosine Kinase Treatment Market 2016-2021

7 North America
    7.1 North America Receptor Tyrosine Kinase Treatment Market by Country 2016-2021
        7.1.1 North America Receptor Tyrosine Kinase Treatment Sales by Country
        7.1.2 North America Receptor Tyrosine Kinase Treatment Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Receptor Tyrosine Kinase Treatment Market by Country 2016-2021
        8.1.1 Europe Receptor Tyrosine Kinase Treatment Sales by Country
        8.1.2 Europe Receptor Tyrosine Kinase Treatment Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Receptor Tyrosine Kinase Treatment Market by Country 2016-2021
        9.1.1 Asia Pacific Receptor Tyrosine Kinase Treatment Sales by Country
        9.1.2 Asia Pacific Receptor Tyrosine Kinase Treatment Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Receptor Tyrosine Kinase Treatment Market by Country 2016-2021
        10.1.1 South America Receptor Tyrosine Kinase Treatment Sales by Country
        10.1.2 South America Receptor Tyrosine Kinase Treatment Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Receptor Tyrosine Kinase Treatment Market by Country 2016-2021
        11.1.1 Middle East and Africa Receptor Tyrosine Kinase Treatment Sales by Country
        11.1.2 Middle East and Africa Receptor Tyrosine Kinase Treatment Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Roche
        12.1.1 Roche Company Information
        12.1.2 Roche Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.1.3 Roche Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Roche Key Development
    12.2 Pfizer
        12.2.1 Pfizer Company Information
        12.2.2 Pfizer Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.2.3 Pfizer Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Pfizer Key Development
    12.3 Novartis
        12.3.1 Novartis Company Information
        12.3.2 Novartis Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.3.3 Novartis Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Novartis Key Development
    12.4 Merck KGaA
        12.4.1 Merck KGaA Company Information
        12.4.2 Merck KGaA Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.4.3 Merck KGaA Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Merck KGaA Key Development
    12.5 Johnson and Johnson
        12.5.1 Johnson and Johnson Company Information
        12.5.2 Johnson and Johnson Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.5.3 Johnson and Johnson Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Johnson and Johnson Key Development
    12.6 GlaxoSmithKline
        12.6.1 GlaxoSmithKline Company Information
        12.6.2 GlaxoSmithKline Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.6.3 GlaxoSmithKline Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 GlaxoSmithKline Key Development
    12.7 Eton Bioscience
        12.7.1 Eton Bioscience Company Information
        12.7.2 Eton Bioscience Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.7.3 Eton Bioscience Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 GlaxoSmithKline Key Development
    12.9 Boehringer Ingelheim
        12.9.1 Boehringer Ingelheim Company Information
        12.9.2 Boehringer Ingelheim Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.9.3 Boehringer Ingelheim Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Boehringer Ingelheim Key Development
    12.8 Bristol-Myers Squibb
        12.8.1 Bristol-Myers Squibb Company Information
        12.8.2 Bristol-Myers Squibb Receptor Tyrosine Kinase Treatment Product Portfolio, Specification and Application
        12.8.3 Bristol-Myers Squibb Receptor Tyrosine Kinase Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Bristol-Myers Squibb Key Development

13 Global Receptor Tyrosine Kinase Treatment Market Forecast by Region by Type and by Application
    13.1 Global Receptor Tyrosine Kinase Treatment Sales, Revenue Forecast 2022-2027
    13.2 Global Receptor Tyrosine Kinase Treatment Forecast by Regions
        13.2.1 Global Receptor Tyrosine Kinase Treatment Sales Forecast by Region 2022-2027
        13.2.2 Global Receptor Tyrosine Kinase Treatment Revenue Forecast by Region 2022-2027
    13.3 Global Receptor Tyrosine Kinase Treatment Forecast by Type
        13.3.1 Global Receptor Tyrosine Kinase Treatment Sales Forecast by Type 2022-2027
        13.3.2 Global Receptor Tyrosine Kinase Treatment Revenue Forecast by Type 2022-2027
        13.3.3 Global Receptor Tyrosine Kinase Treatment Price Forecast by Type 2022-2027
    13.4 Global Receptor Tyrosine Kinase Treatment Forecast by Application
        13.4.1 Global Receptor Tyrosine Kinase Treatment Sales Forecast by Application 2022-2027
        13.4.2 Global Receptor Tyrosine Kinase Treatment Revenue Forecast by Application 2022-2027
        13.4.3 Global Receptor Tyrosine Kinase Treatment Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

Global Receptor Tyrosine Kinase Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

NEED Help?

USA : +1 (661) 636 6162

INDIA : +91 9325802062